Impact of Different CRRT Modalities, Dosing Strategies, and Timing on Kidney Recovery and Prolonged Kidney Dysfunction

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCroatian Society for Organ Support

About this trial

KARMA study is a hospital-based research study looking at how different ways of delivering kidney support therapy (CRRT) affect patients who are critically ill. In some cases, the kidneys may temporarily stop working in very sick patients, and machines are used to filter the blood. This study is exploring whether the way the investigators use these machines - how early to start, how much treatment to give, and what type to choose - makes a difference in how well the kidneys recover. By learning from many hospitals and hundreds of patients, KARMA hopes to improve treatment choices and help patients regain their kidney function faster.

Eligibility criteria

Qualifiers

Acute kidney injury

ICU administration

Disqualifiers

Pre-existing CKD (GFR < 30 ml/min/1,73m2)

Chronic dialysis-dependent end-stage renal failure

Trial design

Treatments tested in this trial

  • Continuos renal replacement therapy

Treatment groups

No treatment groups listed

Locations

This trial has no locations